<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font3" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font4" size="9" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font5" size="9" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font6" size="8" family="AkzidenzGroteskBE" color="#ffffff"/>
	<fontspec id="font7" size="8" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
<text top="42" left="306" width="62" height="7" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="text"><b>Available online</b></text>
<text top="42" left="370" width="186" height="7" font="font2" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="text">http://breast-cancer-research.com/content/7/6/R1028</text>
<text top="735" left="569" width="23" height="8" font="font3" id="p1_t3" reading_order_no="113" segment_no="11" tag_type="text">R1032</text>
<text top="567" left="57" width="240" height="9" font="font4" id="p1_t4" reading_order_no="80" segment_no="7" tag_type="text">cells in carcinomas with squamous metaplasia are not infre-</text>
<text top="579" left="57" width="240" height="9" font="font4" id="p1_t5" reading_order_no="81" segment_no="7" tag_type="text">quent. In fact, in the seminal study conducted by Huvos and</text>
<text top="590" left="57" width="240" height="9" font="font4" id="p1_t6" reading_order_no="82" segment_no="7" tag_type="text">coworker<a href="">s [32] </a>these two subtypes of MBCs were classified</text>
<text top="602" left="57" width="240" height="9" font="font4" id="p1_t7" reading_order_no="83" segment_no="7" tag_type="text">under the heading 'group 1' MBCs. In addition, when EGFR is</text>
<text top="614" left="57" width="240" height="9" font="font4" id="p1_t8" reading_order_no="84" segment_no="7" tag_type="text">overexpressed in carcinomas with heterologous elements and</text>
<text top="626" left="57" width="240" height="9" font="font4" id="p1_t9" reading_order_no="85" segment_no="7" tag_type="text">matrix producing breast carcinomas, its expression appears to</text>
<text top="637" left="57" width="240" height="9" font="font4" id="p1_t10" reading_order_no="86" segment_no="7" tag_type="text">be more conspicuous in epithelial components (data not</text>
<text top="649" left="57" width="240" height="9" font="font4" id="p1_t11" reading_order_no="87" segment_no="7" tag_type="text">shown). In a recent study, Bhargava and cowo<a href="">rkers [8] de</a>m-</text>
<text top="661" left="57" width="240" height="9" font="font4" id="p1_t12" reading_order_no="88" segment_no="7" tag_type="text">onstrated that 6% (11/175) of all breast carcinomas exhibit</text>
<text top="673" left="57" width="24" height="9" font="font5" id="p1_t13" reading_order_no="89" segment_no="7" tag_type="text"><i>EGFR</i></text>
<text top="673" left="81" width="216" height="9" font="font4" id="p1_t14" reading_order_no="90" segment_no="7" tag_type="text"> amplification. Interestingly, one of these 11 cases was</text>
<text top="684" left="57" width="240" height="9" font="font4" id="p1_t15" reading_order_no="91" segment_no="7" tag_type="text">a spindle cell metaplastic carcinoma with focal squamous dif-</text>
<text top="696" left="57" width="240" height="9" font="font4" id="p1_t16" reading_order_no="92" segment_no="7" tag_type="text">ferentiation. Taken together, these findings suggest that</text>
<text top="708" left="57" width="240" height="9" font="font4" id="p1_t17" reading_order_no="93" segment_no="7" tag_type="text">EGFR overexpression and/or gene amplification are likely to</text>
<text top="720" left="57" width="240" height="9" font="font4" id="p1_t18" reading_order_no="94" segment_no="7" tag_type="text">play a role in carcinomas with squamous elements and spindle</text>
<text top="567" left="315" width="240" height="9" font="font4" id="p1_t19" reading_order_no="95" segment_no="8" tag_type="text">cell carcinomas, but perhaps not in the other subtypes of</text>
<text top="579" left="315" width="23" height="9" font="font4" id="p1_t20" reading_order_no="96" segment_no="8" tag_type="text">MBC.</text>
<text top="602" left="315" width="240" height="9" font="font4" id="p1_t21" reading_order_no="97" segment_no="9" tag_type="text">Because the methods used by Bhargava and coworker<a href="">s [8]</a></text>
<text top="614" left="315" width="240" height="9" font="font4" id="p1_t22" reading_order_no="98" segment_no="9" tag_type="text">are identical to ours, a direct comparison is feasible. Taken</text>
<text top="626" left="315" width="240" height="9" font="font4" id="p1_t23" reading_order_no="99" segment_no="9" tag_type="text">together, our results and those of Bhargava and coworkers</text>
<text top="637" left="315" width="50" height="9" font="font4" id="p1_t24" reading_order_no="100" segment_no="9" tag_type="text">indicate that </text>
<text top="637" left="366" width="24" height="9" font="font5" id="p1_t25" reading_order_no="101" segment_no="9" tag_type="text"><i>EGFR</i></text>
<text top="637" left="390" width="166" height="9" font="font4" id="p1_t26" reading_order_no="102" segment_no="9" tag_type="text"> amplification is statistically more prevalent</text>
<text top="649" left="315" width="240" height="9" font="font4" id="p1_t27" reading_order_no="103" segment_no="9" tag_type="text">in MBCs than in other types of breast carcinoma (10/174 non-</text>
<text top="661" left="315" width="241" height="9" font="font4" id="p1_t28" reading_order_no="104" segment_no="9" tag_type="text">metaplastic breast carcinomas versus 8/26 metaplastic breast</text>
<text top="673" left="315" width="88" height="9" font="font4" id="p1_t29" reading_order_no="105" segment_no="9" tag_type="text">carcinomas showed </text>
<text top="673" left="404" width="24" height="9" font="font5" id="p1_t30" reading_order_no="106" segment_no="9" tag_type="text"><i>EGFR</i></text>
<text top="673" left="428" width="64" height="9" font="font4" id="p1_t31" reading_order_no="107" segment_no="9" tag_type="text"> amplification; </text>
<text top="673" left="492" width="9" height="9" font="font5" id="p1_t32" reading_order_no="108" segment_no="9" tag_type="text"><i>P </i></text>
<text top="673" left="504" width="51" height="9" font="font4" id="p1_t33" reading_order_no="109" segment_no="9" tag_type="text">&lt; 0.001 by</text>
<text top="684" left="315" width="122" height="9" font="font4" id="p1_t34" reading_order_no="110" segment_no="9" tag_type="text">Fisher's exact test (two sided)).</text>
<text top="708" left="315" width="240" height="9" font="font4" id="p1_t35" reading_order_no="111" segment_no="10" tag_type="text">Although EGFR amplification accounted for 37% of EGFR</text>
<text top="720" left="315" width="240" height="9" font="font4" id="p1_t36" reading_order_no="112" segment_no="10" tag_type="text">overexpression in the present series, the majority of cases</text>
<text top="85" left="57" width="31" height="7" font="font0" id="p1_t37" reading_order_no="2" segment_no="1" tag_type="title"><b>Figure 2</b></text>
<text top="282" left="57" width="282" height="7" font="font6" id="p1_t38" reading_order_no="3" segment_no="2" tag_type="text">EGFR and HER2 overexpression and gene amplification in a spindle cell carcinoma</text>
<text top="282" left="57" width="286" height="7" font="font2" id="p1_t39" reading_order_no="4" segment_no="2" tag_type="text">EGFR and HER2 overexpression and gene amplification in a spindle cell carcinoma. </text>
<text top="282" left="342" width="12" height="7" font="font1" id="p1_t40" reading_order_no="5" segment_no="2" tag_type="text"><b>(a) </b></text>
<text top="282" left="355" width="201" height="7" font="font2" id="p1_t41" reading_order_no="6" segment_no="2" tag_type="text">Photomicrograph of a spindle cell carcinoma (haematoxylin </text>
<text top="291" left="57" width="174" height="7" font="font2" id="p1_t42" reading_order_no="7" segment_no="2" tag_type="text">and eosin). Immunohistochemical analysis revealed </text>
<text top="291" left="231" width="12" height="7" font="font1" id="p1_t43" reading_order_no="8" segment_no="2" tag_type="text"><b>(b) </b></text>
<text top="291" left="243" width="103" height="7" font="font2" id="p1_t44" reading_order_no="9" segment_no="2" tag_type="text">EGFR grade 3+ positivity and </text>
<text top="291" left="346" width="12" height="7" font="font1" id="p1_t45" reading_order_no="10" segment_no="2" tag_type="text"><b>(c) </b></text>
<text top="291" left="358" width="90" height="7" font="font2" id="p1_t46" reading_order_no="11" segment_no="2" tag_type="text">HER2 grade 2+ reactivity. </text>
<text top="291" left="448" width="12" height="7" font="font1" id="p1_t47" reading_order_no="12" segment_no="2" tag_type="text"><b>(d) </b></text>
<text top="291" left="461" width="72" height="7" font="font2" id="p1_t48" reading_order_no="13" segment_no="2" tag_type="text">CISH demonstrating </text>
<text top="291" left="533" width="21" height="7" font="font7" id="p1_t49" reading_order_no="14" segment_no="2" tag_type="text"><i>EGFR</i></text>
<text top="301" left="57" width="363" height="7" font="font2" id="p1_t50" reading_order_no="15" segment_no="2" tag_type="text">amplification (clusters of signals in the nuclei of neoplastic cells). Note the presence of one or two copies of </text>
<text top="301" left="420" width="21" height="7" font="font7" id="p1_t51" reading_order_no="16" segment_no="2" tag_type="text"><i>EGFR</i></text>
<text top="301" left="441" width="103" height="7" font="font2" id="p1_t52" reading_order_no="17" segment_no="2" tag_type="text"> in stromal cells (arrowheads). </text>
<text top="301" left="544" width="12" height="7" font="font1" id="p1_t53" reading_order_no="18" segment_no="2" tag_type="text"><b>(e) </b></text>
<text top="310" left="57" width="32" height="7" font="font2" id="p1_t54" reading_order_no="19" segment_no="2" tag_type="text">CISH for </text>
<text top="310" left="89" width="21" height="7" font="font7" id="p1_t55" reading_order_no="20" segment_no="2" tag_type="text"><i>HER2</i></text>
<text top="310" left="110" width="244" height="7" font="font2" id="p1_t56" reading_order_no="21" segment_no="2" tag_type="text"> gene: no amplification (2â€“3 gene copies/nucleus). CISH, chromogenic </text>
<text top="310" left="354" width="23" height="7" font="font7" id="p1_t57" reading_order_no="22" segment_no="2" tag_type="text"><i>in situ </i></text>
<text top="310" left="377" width="176" height="7" font="font2" id="p1_t58" reading_order_no="23" segment_no="2" tag_type="text">hybridization; EGFR, epidermal growth factor recep-</text>
<text top="320" left="57" width="298" height="7" font="font2" id="p1_t59" reading_order_no="24" segment_no="2" tag_type="text">tor; HER, human epidermal growth factor receptor; MBC, metaplastic breast carcinoma.</text>
<text top="344" left="57" width="28" height="7" font="font0" id="p1_t60" reading_order_no="25" segment_no="3" tag_type="title"><b>Table 2</b></text>
<text top="362" left="57" width="437" height="7" font="font0" id="p1_t61" reading_order_no="26" segment_no="4" tag_type="text"><b>Summary of the associations between clinicopathological parameters and EGFR overexpression and amplification</b></text>
<text top="381" left="61" width="35" height="7" font="font2" id="p1_t62" reading_order_no="27" segment_no="5" tag_type="table">Parameter</text>
<text top="381" left="181" width="37" height="7" font="font2" id="p1_t63" reading_order_no="28" segment_no="5" tag_type="table">EGFR IHC</text>
<text top="381" left="275" width="5" height="7" font="font7" id="p1_t64" reading_order_no="29" segment_no="5" tag_type="table"><i>P</i></text>
<text top="381" left="392" width="21" height="7" font="font7" id="p1_t65" reading_order_no="30" segment_no="5" tag_type="table"><i>EGFR</i></text>
<text top="381" left="413" width="21" height="7" font="font2" id="p1_t66" reading_order_no="31" segment_no="5" tag_type="table"> CISH</text>
<text top="381" left="488" width="5" height="7" font="font7" id="p1_t67" reading_order_no="32" segment_no="5" tag_type="table"><i>P</i></text>
<text top="399" left="149" width="30" height="7" font="font2" id="p1_t68" reading_order_no="33" segment_no="5" tag_type="table">Negative</text>
<text top="399" left="209" width="53" height="7" font="font2" id="p1_t69" reading_order_no="34" segment_no="5" tag_type="table">Overexpression</text>
<text top="399" left="372" width="10" height="7" font="font2" id="p1_t70" reading_order_no="35" segment_no="5" tag_type="table">No</text>
<text top="399" left="433" width="32" height="7" font="font2" id="p1_t71" reading_order_no="36" segment_no="5" tag_type="table">Amplified</text>
<text top="417" left="61" width="39" height="7" font="font2" id="p1_t72" reading_order_no="37" segment_no="5" tag_type="table">Age (years)</text>
<text top="417" left="144" width="39" height="7" font="font2" id="p1_t73" reading_order_no="38" segment_no="5" tag_type="table">54.2 (13.3)</text>
<text top="417" left="216" width="39" height="7" font="font2" id="p1_t74" reading_order_no="39" segment_no="5" tag_type="table">48.8 (13.3)</text>
<text top="417" left="296" width="21" height="7" font="font2" id="p1_t75" reading_order_no="40" segment_no="5" tag_type="table">&gt;0.05</text>
<text top="417" left="358" width="39" height="7" font="font2" id="p1_t76" reading_order_no="41" segment_no="5" tag_type="table">50.4 (13.7)</text>
<text top="417" left="429" width="39" height="7" font="font2" id="p1_t77" reading_order_no="42" segment_no="5" tag_type="table">48.8 (12.7)</text>
<text top="417" left="510" width="21" height="7" font="font2" id="p1_t78" reading_order_no="43" segment_no="5" tag_type="table">&gt;0.05</text>
<text top="433" left="61" width="32" height="7" font="font2" id="p1_t79" reading_order_no="44" segment_no="5" tag_type="table">Size (cm)</text>
<text top="433" left="149" width="29" height="7" font="font2" id="p1_t80" reading_order_no="45" segment_no="5" tag_type="table">4.0 (3.2)</text>
<text top="433" left="220" width="29" height="7" font="font2" id="p1_t81" reading_order_no="46" segment_no="5" tag_type="table">4.4 (3.1)</text>
<text top="433" left="296" width="21" height="7" font="font2" id="p1_t82" reading_order_no="47" segment_no="5" tag_type="table">&gt;0.05</text>
<text top="433" left="363" width="29" height="7" font="font2" id="p1_t83" reading_order_no="48" segment_no="5" tag_type="table">3.8 (2.9)</text>
<text top="433" left="434" width="29" height="7" font="font2" id="p1_t84" reading_order_no="49" segment_no="5" tag_type="table">5.9 (3.9)</text>
<text top="433" left="510" width="21" height="7" font="font2" id="p1_t85" reading_order_no="50" segment_no="5" tag_type="table">&gt;0.05</text>
<text top="448" left="61" width="86" height="7" font="font2" id="p1_t86" reading_order_no="51" segment_no="5" tag_type="table">Lympho-vascular invasion</text>
<text top="464" left="87" width="10" height="7" font="font2" id="p1_t87" reading_order_no="52" segment_no="5" tag_type="table">No</text>
<text top="464" left="161" width="5" height="7" font="font2" id="p1_t88" reading_order_no="53" segment_no="5" tag_type="table">2</text>
<text top="464" left="233" width="5" height="7" font="font2" id="p1_t89" reading_order_no="54" segment_no="5" tag_type="table">9</text>
<text top="464" left="296" width="21" height="7" font="font2" id="p1_t90" reading_order_no="55" segment_no="5" tag_type="table">&gt;0.05</text>
<text top="464" left="375" width="5" height="7" font="font2" id="p1_t91" reading_order_no="56" segment_no="5" tag_type="table">9</text>
<text top="464" left="447" width="5" height="7" font="font2" id="p1_t92" reading_order_no="57" segment_no="5" tag_type="table">2</text>
<text top="464" left="510" width="21" height="7" font="font2" id="p1_t93" reading_order_no="58" segment_no="5" tag_type="table">&gt;0.05</text>
<text top="479" left="86" width="13" height="7" font="font2" id="p1_t94" reading_order_no="59" segment_no="5" tag_type="table">Yes</text>
<text top="479" left="161" width="5" height="7" font="font2" id="p1_t95" reading_order_no="60" segment_no="5" tag_type="table">2</text>
<text top="479" left="233" width="5" height="7" font="font2" id="p1_t96" reading_order_no="61" segment_no="5" tag_type="table">9</text>
<text top="479" left="375" width="5" height="7" font="font2" id="p1_t97" reading_order_no="62" segment_no="5" tag_type="table">7</text>
<text top="479" left="447" width="5" height="7" font="font2" id="p1_t98" reading_order_no="63" segment_no="5" tag_type="table">4</text>
<text top="495" left="61" width="123" height="7" font="font2" id="p1_t99" reading_order_no="64" segment_no="5" tag_type="table">Lymph node metastasis at diagnosis</text>
<text top="510" left="87" width="10" height="7" font="font2" id="p1_t100" reading_order_no="65" segment_no="5" tag_type="table">No</text>
<text top="510" left="161" width="5" height="7" font="font2" id="p1_t101" reading_order_no="66" segment_no="5" tag_type="table">3</text>
<text top="510" left="230" width="9" height="7" font="font2" id="p1_t102" reading_order_no="67" segment_no="5" tag_type="table">11</text>
<text top="510" left="296" width="21" height="7" font="font2" id="p1_t103" reading_order_no="68" segment_no="5" tag_type="table">&gt;0.05</text>
<text top="510" left="373" width="9" height="7" font="font2" id="p1_t104" reading_order_no="69" segment_no="5" tag_type="table">10</text>
<text top="510" left="447" width="5" height="7" font="font2" id="p1_t105" reading_order_no="70" segment_no="5" tag_type="table">4</text>
<text top="510" left="510" width="21" height="7" font="font2" id="p1_t106" reading_order_no="71" segment_no="5" tag_type="table">&gt;0.05</text>
<text top="526" left="86" width="13" height="7" font="font2" id="p1_t107" reading_order_no="72" segment_no="5" tag_type="table">Yes</text>
<text top="526" left="161" width="5" height="7" font="font2" id="p1_t108" reading_order_no="73" segment_no="5" tag_type="table">1</text>
<text top="526" left="233" width="5" height="7" font="font2" id="p1_t109" reading_order_no="74" segment_no="5" tag_type="table">5</text>
<text top="526" left="375" width="5" height="7" font="font2" id="p1_t110" reading_order_no="75" segment_no="5" tag_type="table">4</text>
<text top="526" left="447" width="5" height="7" font="font2" id="p1_t111" reading_order_no="76" segment_no="5" tag_type="table">2</text>
<text top="542" left="61" width="70" height="7" font="font2" id="p1_t112" reading_order_no="77" segment_no="6" tag_type="text">CISH, chromogenic </text>
<text top="542" left="130" width="23" height="7" font="font7" id="p1_t113" reading_order_no="78" segment_no="6" tag_type="text"><i>in situ </i></text>
<text top="542" left="153" width="282" height="7" font="font2" id="p1_t114" reading_order_no="79" segment_no="6" tag_type="text">hybridization; EGFR, epidermal growth factor receptor. IHC, immunohistochemistry.</text>
</page>
</pdf2xml>
